Smith v. Wyeth Inc et al
| Hermanell Smith |
| Wyeth Inc, Wyeth Pharmaceuticals Inc, ESI Lederle, Wyeth Ayerst International Inc, Pharmacia Corporation, Pfizer Inc, Greenstone Ltd, Barr Pharmaceuticals Inc, Barr Laboratories Inc, Duramed Pharmaceuticals Inc, Bristol Myers Squibb Company, Solvay Pharmaceuticals Inc, Novo Nordisk Inc, Novartis Pharmaceuticals Corporation, Mead Johnson & Company, Warner Chilcott Inc, Watson Pharmaceuticals Inc and Pharmacia & Upjohn Company |
| 4:2008cv02732 |
| September 17, 2008 |
| US District Court for the Eastern District of Arkansas |
| Personal Inj. Prod. Liability Office |
| Out of State |
| Billy Roy Wilson |
| Personal Inj. Prod. Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 23, 2014. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 40
(This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) ORDER granting #39 Plaintiff's Motion to Dismiss With Prejudice. Accordingly, this CASE is DISMISSED with prejudice. Signed by Judge Billy Roy Wilson on 09/23/14. (dmm)
|
| Filing 39 MOTION to Dismiss by All Plaintiffs (Morrison, Matthew) |
|
Filing 38
ORDER designating cases to proceed with case-specific discovery under Practice and Procedure Order 9. Plaintiff(s) are directed to provide Defendant(s) with updated medical authorization within 3 weeks of the date of this Order. Signed by Judge Billy Roy Wilson on 1/29/2013.(jak)
|
| Filing 37 NOTICE of Appearance by Edward F. Fox on behalf of Wyeth Inc, Wyeth Pharmaceuticals Inc, Wyeth Ayerst International Inc (Fox, Edward) |
| Filing 36 NOTICE of Appearance by Carrie L Hund on behalf of Wyeth Inc, Wyeth Pharmaceuticals Inc, Wyeth Ayerst International Inc (Hund, Carrie) |
| Filing 35 NOTICE of Appearance by Matthew J. Morrison on behalf of Hermanell Smith (Morrison, Matthew) |
| Filing 34 NOTICE of Appearance by Carrie L Hund on behalf of Wyeth Inc, Wyeth Pharmaceuticals Inc (Hund, Carrie) |
| Filing 33 NOTICE of Appearance by Edward F. Fox on behalf of Wyeth Inc, Wyeth Pharmaceuticals Inc (Fox, Edward) |
|
Filing 32
(This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) ORDER granting #31 Defendants' PPO8 Motion to Dismiss. Accordingly, Greenstone LLC f/k/a Greenstone Ltd., Solvay Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Mead Johnson & Company, Novartis Pharmaceuticals Corporation, Warner Chilcott, Inc., and Watson Pharmaceuticals, Inc. are DISMISSED based on the terms and conditions in PPO8. Signed by Judge William R. Wilson, Jr on 12/11/08. (dmm)
|
| Filing 31 MOTION to Dismiss Pursuant to Practice and Procedure Order No. 8 by Greenstone Ltd, Bristol Myers Squibb Company, Solvay Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, Mead Johnson & Company, Warner Chilcott Inc, Watson Pharmaceuticals Inc (Troyer, Brian) |
|
Filing 30
(This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) ORDER granting #29 Defendant's PPO8 Motion to Dismiss. Accordingly, Novo Nordisk, Inc. is DISMISSED based on the terms and conditions in PPO8. Signed by Judge William R. Wilson, Jr on 10/29/08. (dmm)
|
| Filing 29 MOTION to Dismiss PURSUANT TO PRACTICE AND PROCEDURE ORDER NO. 8 by Novo Nordisk Inc (Sterchi, Thomas) |
|
Filing 28
(This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) ORDER granting #27 the Joint Motion to Dismiss With Prejudice Defendants Barr Laboratories, Inc., Barr Pharmceuticals, Inc., and Duramed Pharmaceuticals, Inc. Accordingly, Defendants Barr Laboratories, Inc., Barr Pharmceuticals, Inc., and Duramed Pharmaceuticals, Inc are DISMISSED with prejudice. Signed by Judge William R. Wilson, Jr on 10/20/08. (dmm)
|
| Filing 27 Joint MOTION to Dismiss With Prejudice Defendants Barr Laboratories, Inc., Barr Pharmceuticals, Inc., and Duramed Pharmaceuticals, Inc. Only by Barr Pharmaceuticals Inc, Barr Laboratories Inc, Duramed Pharmaceuticals Inc (Saelinger, Gina) |
| Filing 26 Corporate Disclosure Statement (Rule 7.1) by Novo Nordisk Inc (Lysaught, Patrick) |
| Filing 25 ANSWER to Complaint with Jury Demand and Affirmative Defenses by Novo Nordisk Inc.(Lysaught, Patrick) |
| Filing 24 NOTICE of Appearance by Paul S. Penticuff on behalf of Novo Nordisk Inc (Penticuff, Paul) |
| Filing 23 NOTICE of Appearance by Patrick Lysaught on behalf of Novo Nordisk Inc (Lysaught, Patrick) |
| Filing 22 NOTICE of Appearance by Thomas N. Sterchi on behalf of Novo Nordisk Inc (Sterchi, Thomas) |
| Filing 21 NOTICE of Appearance by Kerry Carson Green on behalf of Watson Pharmaceuticals Inc (Green, Kerry) |
| Filing 20 MEMORANDUM to counsel from the Clerk of Court re: receipt of case from transferor court with a copy of Standing Order dated 8/11/2005 filed in 4:03-cv-1507 attached. (rhm) |
| Filing 19 NOTICE of Appearance by Brian A. Troyer on behalf of Solvay Pharmaceuticals Inc (Troyer, Brian) |
| Filing 18 Case electronically transferred in from District of Minnesota; Case Number 0:08-cv-04428. Electronic file with documents numbered 1 - 17, copy of transfer order and docket sheet received. |
| Filing 17 Certified Copy of Transfer Order (CTO-145) from the Judicial Panel on Multi-District Litigation; transferring case to the Eastern District of Arkansas for coordinated or consolidated pretrial proceedings. Case assigned to Judge William R Wilson, Jr. (kt) [Transferred from mnd on 9/17/2008.] |
|
Filing 16
ADMINISTRATIVE ORDER NO. 1 - Establishing Administrative Case 0:08-ad-0001 for management of Hormone Replacement Therapy Litigation cases in the District of Minnesota. IT IS ORDERED that: Defendants in any HRT action filed in this Court after June 1, 2008 need not answer, or otherwise respond to Plaintiffs' HRT complaints until twenty (20) days after notice of formal transfer or further Order of this Court. It is further Ordered that Defendants who have previously filed a Rule 7.1 Disclosure Statement need not file any further such disclosures unless there is a material change in corporate information. Signed by Chief Judge Michael J. Davis on 7/30/08. (Attachments: #1 Case List) Associated Cases: 0:08-ad-00001 et al. This Order will be entered multiple times for groups of HRT cases filed in the District of Minnesota. (LJG) [Transferred from mnd on 9/17/2008.]
|
| Filing 15 Novartis Pharmaceuticals Corporation's Adoption of Master ANSWER to Complaint by Novartis Pharmaceuticals Corporation. (Borger, John) [Transferred from mnd on 9/17/2008.] |
| Filing 14 CERTIFICATE OF SERVICE by Novartis Pharmaceuticals Corporation re #13 Rule 7.1 - Disclosure Statement, #12 Notice of Appearance (Freestone, Amy) [Transferred from mnd on 9/17/2008.] |
| Filing 13 RULE 7.1 DISCLOSURE STATEMENT by Novartis Pharmaceuticals Corporation of Novartis Finance Corporation, Novartis Corporation, Novartis Holding AG, Novartis AG as corporate parent and/or publicly held company. (Freestone, Amy) [Transferred from mnd on 9/17/2008.] |
| Filing 12 DOCUMENT FILED IN ERROR- WRONG EVENT USED // NOTICE of Appearance by Amy R Freestone on behalf of Novartis Pharmaceuticals Corporation (Freestone, Amy) Modified on 7/29/2008 (lph). [Transferred from mnd on 9/17/2008.] |
|
Filing 11
ORDER APPROVING re #7 Stipulation regarding Answer pending MDL Transfer filed by Novo Nordisk, Inc. Signed by Magistrate Judge Jeanne J. Graham on 7/28/08. (RLR) [Transferred from mnd on 9/17/2008.]
|
|
Filing 10
ORDER OF RECUSAL. Magistrate Judge Susan R. Nelson recused. Case reassigned to Magistrate Judge Jeanne J. Graham for all further proceedings. NOTE: the new case number is 08cv4428 PAM/JJG. Please use this case number for all subsequent pleadings. Signed by Magistrate Judge Susan R. Nelson on 7/28/08. (JME) [Transferred from mnd on 9/17/2008.]
|
| Filing 9 DOCUMENT REMOVED, FILED IN WRONG CASE. INITIAL ANSWER to Complaint by Bristol-Myers Squibb Company. (Attachments: # 1 Certificate of Service) (Morris, Frederick) (Additional attachment(s) added on 7/28/2008: # 2 PLACEHOLDER) (JME). [Transferred from mnd on 9/17/2008.] |
| Filing 8 INITIAL ANSWER to Complaint by Bristol-Myers Squibb Company. (Attachments: #1 Certificate of Service) (Morris, Frederick) [Transferred from mnd on 9/17/2008.] |
| Filing 7 STIPULATION Regarding Extension of Time by Novo Nordisk, Inc.. (Attachments: #1 Certificate of Service)(Newkirk, Christopher) [Transferred from mnd on 9/17/2008.] |
| Filing 6 CERTIFICATE OF SERVICE by Pfizer, Inc., Greenstone, Ltd., Pharmacia and Upjohn Company, Pharmacia Corporation re #5 Rule 7.1 - Disclosure Statement, #4 Answer to Complaint (Iversen, Tara) [Transferred from mnd on 9/17/2008.] |
| Filing 5 RULE 7.1 DISCLOSURE STATEMENT by Pfizer, Inc., Greenstone, Ltd., Pharmacia and Upjohn Company, Pharmacia Corporation that there is no such parent or publicly held corporation to report. (Iversen, Tara) [Transferred from mnd on 9/17/2008.] |
| Filing 4 INITIAL ANSWER to Complaint by Pfizer, Inc., Greenstone, Ltd., Pharmacia and Upjohn Company, Pharmacia Corporation. (Iversen, Tara) [Transferred from mnd on 9/17/2008.] |
| Filing 3 RULE 7.1 DISCLOSURE STATEMENT by Warner Chilcott, Inc. of Warner Chilcott Corporation and Warner Chilcott Limited as corporate parent and/or publicly held company. (Attachments: #1 Certificate of Service)(Weldon, Melissa) [Transferred from mnd on 9/17/2008.] |
| Filing 2 ANSWER to Complaint by Warner Chilcott, Inc.. (Weldon, Melissa) [Transferred from mnd on 9/17/2008.] |
| Filing 1 COMPLAINT against all defendants ( Filing fee $ 350 receipt number 40025210.) assigned to Judge Paul A Magnuson per Master List and referred to Magistrate Judge Susan R Nelson, filed by Hermanell Smith. (Attachments: #1 Civil Cover Sheet) (kt) [Transferred from mnd on 9/17/2008.] |
| Summons Issued as to Pfizer, Inc., Greenstone, Ltd., Barr Pharmaceuticals, Inc., Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Solvay Pharmaceuticals, Inc., Novo Nordisk, Inc., Novartis Pharmaceuticals Corporation, Mead-Johnson & Company, Warner Chilcott, Inc., Watson Pharmaceuticals, Inc., Wyeth, Inc., Wyeth Pharmaceuticals Inc., ESI Lederle, Wyeth-Ayerst International, Inc., Pharmacia and Upjohn Company, Pharmacia Corporation. (kt) [Transferred from mnd on 9/17/2008.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Arkansas Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
